NEURONTIN® 800 mg Tablets, single dose
Sponsors
Actavis Inc.
Conditions
Healthy
Phase 1
A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Fasting Conditions
CompletedNCT00865423
Start: 2001-02-28End: 2001-03-31Updated: 2010-08-17
A Relative Bioavailability Study of Gabapentin Tablets 800 mg Under Non-fasting Conditions
CompletedNCT00865059
Start: 2001-02-28End: 2001-03-31Updated: 2010-08-17